⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3921147 | 0.67 | — | — | |
| SCHEMBL7528575 | 0.67 | — | — | |
| SCHEMBL126796 | 0.65 | — | — | |
| SCHEMBL15821145 | 0.65 | — | — | |
| SCHEMBL3580993 | 0.65 | — | — | |
| SCHEMBL13458383 | 0.65 | — | — | |
| SCHEMBL1399300 | 0.63 | — | — | |
| SCHEMBL1904144 | 0.63 | — | — | |
| SCHEMBL19615627 | 0.63 | — | — | |
| SCHEMBL11443620 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100089529-A1 | MICROFLUIDIC DEVICES AND PRODUCTION METHODS THEREFOR | INVERNESS MEDICAL SWITZERLAND GMBH (CH) | 2010-04-15 | — | — | US | claimed |
| EP-1843849-A2 | A METHOD OF PRODUCING A MICROFLUIDIC DEVICE AND MICROFLUIDIC DEVICES | Inverness Medical Switzerland GmbH (CH) | 2007-10-17 | — | — | EP | claimed |
| WO-2006074665-A2 | A METHOD OF PRODUCING A MICROFLUIDIC DEVICE AND MICROFLUIDIC DEVICES | INVERNESS MEDICAL SWITZERLAND GMBH (CH) | 2006-07-20 | — | — | WO | claimed |
| US-20110200986-A1 | BIO-ASSAY USING LIQUID CRYSTALS | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2011-08-18 | — | — | US | disclosed |
| US-20100089529-A1 | MICROFLUIDIC DEVICES AND PRODUCTION METHODS THEREFOR | INVERNESS MEDICAL SWITZERLAND GMBH (CH) | 2010-04-15 | — | — | US | disclosed |
| WO-2010042070-A1 | BIO-ASSAY USING LIQUID CRYSTALS | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2010-04-15 | — | — | WO | disclosed |
| EP-1620651-A4 | MICROFLUIDIC DEVICES AND METHODS | PREDICANT BIOSCIENCES INC (US) | 2007-12-05 | — | — | EP | disclosed |
| EP-1843849-A2 | A METHOD OF PRODUCING A MICROFLUIDIC DEVICE AND MICROFLUIDIC DEVICES | Inverness Medical Switzerland GmbH (CH) | 2007-10-17 | — | — | EP | disclosed |
| WO-2006074665-A2 | A METHOD OF PRODUCING A MICROFLUIDIC DEVICE AND MICROFLUIDIC DEVICES | INVERNESS MEDICAL SWITZERLAND GMBH (CH) | 2006-07-20 | — | — | WO | disclosed |
| US-7007710-B2 | Microfluidic devices and methods | PREDICANT BIOSCIENCES, INC. (US) | 2006-03-07 | — | — | US | disclosed |
| EP-1620651-A2 | MICROFLUIDIC DEVICES AND METHODS | Predicant Biosciences, Inc. (US) | 2006-02-01 | — | — | EP | disclosed |
| US-20050000569-A1 | Microfluidic devices and methods | BIOSPECT, INC. A DELAWARE CORPORATION (US) | 2005-01-06 | — | — | US | disclosed |
| WO-2004094994-A2 | MICROFLUIDIC DEVICES AND METHODS | PREDICANT BIOSCIENCES, INC. (US) | 2004-11-04 | — | — | WO | disclosed |
| US-20040206399-A1 | Microfluidic devices and methods | BIOSPECT, INC. (US) | 2004-10-21 | — | — | US | disclosed |